Short Description: Board of Pharmacy required to adopt rules regarding the substitution of drugs used for the treatment of epilepsy or seizure if the United States Food and Drug Administration determines that substitution may cause a health risk to patients.
Did not find what you were looking for? Search the House Bill Information System.